ReviewFrontiers in immunology2025

Case report and literature review: tislelizumab combined with lenvatinib and polymeric micellar paclitaxel for thymic squamous cell carcinoma.

Jingwen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.